Back

Xanthine oxidase inhibitors withdrawal syndrome

27 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Clinical pharmacology Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Masanari Kuwabara

Jichi Medical University, Shimotsuke (Japan)

7 More presentations in this session

Presentation thumbnail
Temporal trends of first time antihypertensive treatment among citizens over 75 years - a register-based, cohort study
Mr S. Nielsen (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats
Doctor J. Wikstrom (SE)
Abstract Slides Video
Presentation thumbnail
RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Amiodarone induced thyroid dysfunction.
Doctor P. Gudjonsson (Reykjavik, IS)
Abstract Slides Video
Presentation thumbnail
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study.
Doctor B. Al-Abbasi (Roskilde, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical pharmacology

The Event

Event poster

ESC Congress 2023

27 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Xanthine oxidase inhibitors in cardiovascular disease: impact on mortality and ATP dynamics
thumbnail
Congress Presentation
Comparative clinical outcomes on renal function and mortality of uricosuric agents versus xanthine oxidase inhibitors in patients with hyperuricemia and cardiovascular risks
thumbnail
Congress Session
Novel drugs for cardiovascular diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources